The highest estimate is 21.00. From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
43%
Hold
57%
Sell
0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow AARD.BOATS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Its lead product candidate is the ARD-101, an oral gut-restricted small-molecule agonist of certain targeting bitter taste receptors expressed in the gut lumen that is in Phase III clinical trial for hyperphagia associated with Prader-Willi Syndrome, as well as in Phase II clinical trial for hyperphagia associated with acquired hypothalamic obesity resultant from treatment of craniopharyngioma, including surgery or radiation. It also developing ARD-201, which is in Phase I clinical trial for the treatment of obesity. The company was incorporated in 2017 and is based in San Diego, California.
The current price of AARD.BOATS is $3.92 USD — it has increased by +7.4% in the past 24 hours. Watch Aardvark Therapeutics stock price performance more closely on the chart.
What is Aardvark Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aardvark Therapeutics stocks are traded under the ticker AARD.BOATS.
What is Aardvark Therapeutics market cap?▼
Today Aardvark Therapeutics has the market capitalization of 85.35M
When is the next Aardvark Therapeutics earnings date?▼
Aardvark Therapeutics is going to release the next earnings report on May 20, 2026.
What were Aardvark Therapeutics earnings last quarter?▼
AARD.BOATS earnings for the last quarter are -0.81 USD per share, whereas the estimation was -0.83 USD resulting in a +2.09% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Aardvark Therapeutics revenue for the last year?▼
Aardvark Therapeutics revenue for the last year amounts to 0 USD.
What is Aardvark Therapeutics net income for the last year?▼
AARD.BOATS net income for the last year is -41.18M USD.
When did Aardvark Therapeutics complete a stock split?▼
Aardvark Therapeutics has not had any recent stock splits.